Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Idiopathic Menorrhagia
Interventions: Drug: Levonorgestrel (Mirena, BAY86-5028); Drug: Hormonal treatment; Drug: Antifibrinolytic treatment
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Contraception
Interventions: Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016)
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Pharmacokinetics
Interventions: Drug: Acetylsalicylic Acid (Aspirin BAY1019036); Drug: Alka Seltzer Extra Strength; Drug: Aspirin Migraine; Drug: Aspirin Aspro
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Drug: Betaseron (Interferon beta-1b, BAY86-5046)
Sponsor: Bayer
Not yet recruiting - verified March 2010
Condition: Infection
Interventions: Drug: Cephalexin capsules (Optocef, BAY o5448 ); Drug: Cephalexin capsules (Keflex)
Sponsors: Bayer; Corporación Bonima S.A. de C.V.
Completed - verified February 2010
Condition: Healthy
Interventions: Drug: Levonorgestrel Emergency Pill (BAY86-5028); Drug: Postinor 2
Sponsor: Bayer
Completed - verified February 2010
Condition: Infection
Interventions: Drug: Cephalexin suspension (Optocef, BAYO5448); Drug: Cephalexin suspension (Keflex)
Sponsors: Bayer; Corporación Bonima S.A. de C.V.
Completed - verified February 2010
Condition: Healthy
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Moxifloxacin (Avelox, BAY12-8039)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Alemtuzumab; Drug: Rituximab
Sponsors: M.D. Anderson Cancer Center; Bayer
Active, not recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Hypertension
Interventions: Drug: Nifedipine (Adalat, BAYA1040) and Valsartan; Drug: Nifedipine (Adalat, BAYA1040); Drug: Valsartan
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Pharmacokinetics
Interventions: Drug: Acetylsalicylic acid (Aspirin, BAY1019036); Drug: Acetylsalicylic acid (Aspirin, BAY1019036); Drug: Acetylsalicylic acid (Aspirin, BAYE4465); Drug: Acetylsalicylic acid (Aspirin, BAYE4465)
Sponsor: Bayer
Completed - verified February 2010
Condition: Melanoma
Interventions: Drug: bortezomib; Drug: sorafenib
Sponsors: Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Massachusetts General Hospital; Brigham and Women's Hospital; Bayer; Millennium Pharmaceuticals, Inc.
Not yet recruiting - verified March 2010
Condition: Intra-abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsor: Bayer
Not yet recruiting - verified March 2010
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Cancer
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006); Drug: Nexavar (Sorafenib, BAY43-9006); Drug: Nexavar (Sorafenib, BAY43-9006); Drug: Paclitaxel; Drug: Carboplatin; Drug: Bevacizumab
Sponsor: Bayer
Recruiting - verified February 2010
All Categories ... by Company » ... Bayer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
